The investigators need stronger feedback loops and a quality monitoring and management system to improve the quality of care in sustainable way. The Chair Sint-Trudo "To a sustainable quality policy" was established to scientifically develop prerequisites for a sustainable quality of care. In this study protocol, a monocentric mixed-method quasi-experimental study will be used to assess the impact of a rapid-cycle quality indicator feedback mechanism on both patients and professionals.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
400
1. Audit and feedback: A summary of clinical performance and hospital safety culture over a specified period of time. 2. Benchmarking Achievable: benchmarks are calculated from the performance of all members of a peer group and represents a realistic standard of excellence attained by the top performers in that group (i.e. comparing to the top 10% of peers). 3. Educational outreach: A trained independent person or investigator will meet with health professionals or managers in their practice setting to provide information (e.g. feedback of quality indicators). 4. Action planning: The purpose of action planning is to support quality improvement efforts by identifying opportunities for improvement, strategies and steps to accomplish the work.
Sint-Trudo Ziekenhuis
Sint-Truiden, Belgium
Hospital mortality
In-hospital mortality rate
Time frame: During admission
Patient experiences
Experiences of patients will be measures by a validated questionnaire (Flemisch Patient Experience Questionnaire). Q: Will you recommend our hospital? (scale min 0 until 10 with 0: not and 10: for sure). For follow questions the scores are 'disagree', 'somewhat agree', 'largely agree', 'totally agree. The higher the score the better the outcome Q: This information was provided by my GP or by healthcare providers in the hospital. Q: I understand the information I received about the cost of my stay. Q: I received sufficient information about the causes of my condition or about the possible treatment methods for my condition or about the consequences of my disease. Q: Nurses or doctors explained things in a way I could understand or treated me with courtesy and respect. Q: My privacy was respected during conversations with caregivers or during examinations, treatment and care. Q: Before any treatment my identity was checked. Q: Hospital staff always introduced themselves
Time frame: During admission
In-hospital length of stay
Length of stay of each patient in the hospital
Time frame: During admission
Adverse events and adverse outcomes
Each adverse event and following adverse outcomes will be measured: urinary tract infections, pressure ulcers, hospital-acquired pneumonia, shock/cardiac arrest, upper-gastrointestinal bleeding, hospital-acquired sepsis, deep venous thrombosis, central nervous system complications, surgical wound infection, pulmonary failure, metabolic derangement, methicillin-resistant Staphylococcus aureus, vancomycin resistant Enterococcus, central line associated bloodstream infections, carbapenemase producing Enterobacteriaceae
Time frame: During admission
Failure to rescue rate
The failure to rescue rate for each patient admitted in the hospital will be evaluated
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: During admission
Readmission rate
Readmission within 30 days of each patient admitted in the hospital
Time frame: 30 days after discharge